Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users

Journal: Science Translational Medicine

Published: 2018-07-11

DOI: 10.1126/scitranslmed.aao4496

Affiliations: 8

Authors: 11

Go to article
Institutions FC
Department of Medicine, LUC, United States of America (USA) 0.27
Center for Biologics Evaluation and Research (CBER), USFDA, United States of America (USA) 0.27
Division of Epidemiology and Biostatistics, UIC, United States of America (USA) 0.14
The Kirby Institute, UNSW, Australia 0.09
UNM Department of Internal Medicine (DOIM), United States of America (USA) 0.09
Department of Physics, BIU, Israel 0.05
Disease Elimination Program, Burnet Institute, Australia 0.05
Department of Medicine and Radiology, UniMelb, Australia 0.05